Quick Answer
IDEAYA Biosciences, Inc. reported Earnings Per Share Diluted of $1.28 (loss) per share for the year ending 2025.
- IDEAYA Biosciences, Inc. showed an increase of +61.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from IDEAYA Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.33 (loss) per share | Q3 2021: $0.31 (loss) per share | Q1 2022: $0.36 (loss) per share | Q2 2022: $0.57 (loss) per share | Q3 2022: $0.04 per share | Q1 2023: $0.49 (loss) per share | Q2 2023: $0.50 (loss) per share | Q3 2023: $0.46 (loss) per share | Q1 2024: $0.53 (loss) per share | Q2 2024: $0.68 (loss) per share | Q3 2024: $0.60 (loss) per share | Q1 2025: $0.82 (loss) per share | Q2 2025: $0.88 (loss) per share | Q3 2025: $1.33 per share.
- Over the full 6 years of available data (2020 to 2025), IDEAYA Biosciences, Inc.'s Earnings Per Share Diluted has grown by 8.6%.
- Historical annual values: Fiscal year 2025: $1.28 (loss) per share | Fiscal year 2024: $3.36 (loss) per share | Fiscal year 2023: $1.96 (loss) per share | Fiscal year 2022: $1.42 (loss) per share | Fiscal year 2021: $1.41 (loss) per share | Fiscal year 2020: $1.40 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: